{
    "2021-03-19": [
        [
            {
                "time": "2021-03-19",
                "original_text": "研发正火，辉瑞却“悄悄”转手他人！ADC会成为下一个PD-1吗？",
                "features": {
                    "keywords": [
                        "研发",
                        "辉瑞",
                        "ADC",
                        "PD-1"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "诺和诺德司美鲁肽、恒瑞医药SHR6390片等产品拟突破性治疗；药明生物收购苏桥生物，与康桥资本合作生物药开发",
                "features": {
                    "keywords": [
                        "诺和诺德",
                        "恒瑞医药",
                        "药明生物",
                        "突破性治疗",
                        "生物药开发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "创新药突围需破产业链关键一环",
                "features": {
                    "keywords": [
                        "创新药",
                        "产业链"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "医药生物行业：业绩弹性逐步释放 关注一季报高增长品种",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩弹性",
                        "一季报",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "A股融资融券日报：两融余额增加0.67亿元（3月18日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "A股"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "基金进入“倒春寒”？3月超20只基金延长募集期",
                "features": {
                    "keywords": [
                        "基金",
                        "倒春寒",
                        "募集期"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "反弹基本到位，谨防二次探底",
                "features": {
                    "keywords": [
                        "反弹",
                        "二次探底"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}